Dosidal · Singapore

HCQS HYDROXYCHLOROQUINE TABLET BP 200 mg

Dosidal is a product record. It identifies a medicine and its regulatory status. It does not advise on use.

MarketSingapore
Recordsg:authorisation:SIN16632P (version 1)
Levelauthorisation
Pack codenot anchored
Identifierssg-hsa-licence: SIN16632P
Source authorityHSA
Read date2026-08-07T09:43:28Z
authorisation statuslisting: Listing of Registered Therapeutic Products
registered: True
state: current · read 2026-08-07T09:43:28Z · source: Health Sciences Authority (HSA), via data.gov.sg page
identityapproval_date_as_published: 28/10/2022
atc: P01BA02
country_of_manufacture: INDIA
dosage_form: TABLET, FILM COATED
holder: ZYFAS PHARMA PTE LTD
licence_number: SIN16632P
manufacturer: IPCA LABORATORIES LIMITED
product: HCQS HYDROXYCHLOROQUINE TABLET BP 200 mg
route: ORAL
strength: 200 mg
substances: HYDROXYCHLOROQUINE SULPHATE
state: current · read 2026-08-07T09:43:28Z · source: Health Sciences Authority (HSA), via data.gov.sg page
prescription classclass: prescription
forensic_classification: Prescription Only
state: current · read 2026-08-07T09:43:28Z · source: Health Sciences Authority (HSA), via data.gov.sg page
SignatureES256 over JCS, key dosidal-record-1.9dbf5d53
orrJd0FRsMu2RFpDWXAkqGMB0ExgE57FMbPUcOfVmAa5OjHY0JBp955tpct6DjayREG5-MEcdFwYHN7g-8fq9g
Verify with verify_record (MCP) or POST https://dosidal-api.ai/v1/verify/record; keyring https://dosidal-registry.ai/.well-known/jwks.json

JSON: https://dosidal-api.ai/v1/records/sg:authorisation:SIN16632P · Same medicine in other markets · Dosidal